SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-99-000693
Filing Date
1999-02-12
Accepted
1999-02-12 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 DUSA PHARMACEUTICALS, INC. SC 13G 9239
  Complete submission text file 0000950135-99-000693.txt   11343
Mailing Address
Business Address 99 SUMMER ST BOSTON MA 02110 6172610681
FRONTIER CAPITAL MANAGEMENT CO INC /ADV (Filed by) CIK: 0000733581 (see all company filings)

IRS No.: 042715137 | State of Incorp.: MA | Fiscal Year End: 1231

Mailing Address 181 UNIVERSITY AVE STE 1208 TORONTO ONTARIO M5H 3M7 CANADA A6
Business Address 181 UNIVERSITY AVE, STE 1208 TORONTO, ONTARIO, CANADA M5H 3M7 A6 4163635059
DUSA PHARMACEUTICALS INC (Subject) CIK: 0000879993 (see all company filings)

IRS No.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42248 | Film No.: 99534576
SIC: 2834 Pharmaceutical Preparations